Supriya Lifescience, a leading active pharmaceutical ingredients (APIs) manufacturer and supplier, filed DRHP with SEBI to fundraise Rs. 1,200 cores through IPO. The said initial public offer will comprise a new issue of shares worth Rs. 200 crores. It will also consist of an offer for sale (OFS) of a maximum of Rs. 1,000 crores. …